Focus on MEDEC Members Making a Difference in Canadian Healthcare — MEDEC 2015 M11
Outstanding results from the market-leading global endometrial ablation system:
NovaSure Endometrial Ablation: a safe, comfortable procedure in the operating room or clinic setting ®
• Average 90-second treatment time • 73% of patients in the pivotal trial received IV or local sedation • 93% patient satisfaction in pivotal trial 1
• Post-procedural pain and cramping rates: – Over 97% of patients experienced no procedural pain at less than 24 hours to 2 weeks
avoidance of hysterectomy at 5 years 3
9 out of 10
patients return to normal levels of bleeding or lower
For more information, contact email@example.com
REFERENCES: 1. Cooper J, Gimpelson R, Laberge P et al. A randomized, multicenter trial of safety and efﬁcacy of the Novasure System in the treatment of menorrhagia. J Am Assoc Gynecol Laparosc. 2002;9:418-428 2. NovaSure Instructions for Use 3. Gallinat A. An impedance-controlled system for endometrial ablation: Five-year follow up on 107 patients. J Reprod Med. 2007; 52:467-472 ©2015 Hologic, Inc. Printed in USA. Hologic, NovaSure and The Science of Sure are trademarks or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries. This information is intended for medical professionals in the U.S. and other markets and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic materials are distributed through websites, eBroadcasts and tradeshows, it is not always possible to control where such materials appear. For speciﬁc information on what products are available for sale in a particular country, please contact your local Hologic representative or write to firstname.lastname@example.org.
FEBRUARY 2015 HOSPITAL NEWS
Technology in Healthcare, Patient Experience & Hospital Performance Indicators. Special MEDEC Annual Supplement.